Effect of a low-fat diet combined with IGF-1 receptor blockade on 22Rv1 prostate cancer xenografts.
Mol. Cancer Ther., Jul;11(7):1539-46 (2012)
The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice.
Metab. Clin. Exp., Mar;59(3):343-9 (2010)
Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer.
J. Urol., Jan;183(1):345-50 (2010)
Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index.
Cancer Res., Feb;70(4):1564-72 (2010)
Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
J. Clin. Endocrinol. Metab., May;95(5):2089-98 (2010)
Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy.
Cancer Prev Res (Phila)., Dec;4(12):2062-71 (2011)
Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit.
Growth Horm. IGF Res., Feb;18(1):65-74 (2008)
A mechanism to explain how regular exercise might reduce the risk for clinical prostate cancer.
Eur. J. Cancer Prev., Oct;16(5):415-21 (2007)
The somatomedin hypothesis 2007: 50 years later.
J. Clin. Endocrinol. Metab., Dec;92(12):4529-35 (2007)
Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model.
Cancer Res., Apr;68(8):3066-73 (2008)
Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression.
Cancer Res., May;68(9):3342-9 (2008)
PAPA-1 Is a nuclear binding partner of IGFBP-2 and modulates its growth-promoting actions.
Mol. Endocrinol., Feb;23(2):169-75 (2009)
Overview of the IGF-I system.
Horm. Res., 65 Suppl 1:3-8 (2006)
Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age.
Endocrinology., May;147(5):2109-11 (2006)
Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2.
Clin. Cancer Res., Aug;12(15):4662-70 (2006)
Controversy in clinical endocrinology: problems with reclassification of insulin-like growth factor I production and action disorders.
J. Clin. Endocrinol. Metab., Nov;91(11):4235-6 (2006)
Growth hormone therapy improves bone mineral density in children with cerebral palsy: a preliminary pilot study.
J. Clin. Endocrinol. Metab., Mar;92(3):932-7 (2007)
Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
J. Clin. Endocrinol. Metab., Jul;92(7):2480-6 (2007)
Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3.
Carcinogenesis., Aug;28(8):1653-8 (2007)
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults.
Proc. Natl. Acad. Sci. U.S.A., Mar;101(13):4531-6 (2004)